Celcuity Inc. (NASDAQ:CELC) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET
Company Participants
Apoorva Chaloori – ICR Healthcare, Investor Relations
Brian Sullivan – Co-Founder & Chief Executive Officer
Vicky Hahne – Chief Financial Officer
Conference Call Participants
Maury Raycroft – Jefferies
Brad Canino – Stifel
Oliver McCammon – LifeSci Capital
Gil Blum – Needham Corporation
Chase Knickerbocker – Craig-Hallum Capital Group
Operator
Good afternoon, ladies and gentlemen, and welcome to the Celcuity Fourth Quarter and Full Year 2024 Financial Results Webcast Conference Call. [Operator Instructions]
I would now like to turn the conference over to Apoorva Chaloori with ICR Healthcare. Please go ahead.
Apoorva Chaloori
Thank you, operator, and good afternoon to everyone on the call. Thank you for joining us to review Celcuity’s fourth quarter and full year 2024 financial results and business update. Earlier today, Celcuity released financial results for the fourth quarter ending December 31, 2024. The press release can be found on the Investors section of the website.
Joining me on the call today are Brian Sullivan, Celcuity’s Chief Executive Officer and Co-Founder; Vicky Hahne, Chief Financial Officer; as well as Igor Gorbatchevsky, Chief Medical Officer, who will be available during Q&A.
Before we begin, I would like to remind listeners that our comments today will include some forward-looking statements. These statements involve a number of risks and uncertainties, which are outlined in today’s press release and in our reports and filings with the SEC. Actual events or results may differ materially from those projected in the forward-looking statements. Such forward-looking statements and their implications involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected.
On this call, we will also refer to non-GAAP financial measures. These non-GAAP measures are used by management
#Celcuity #CELC #Earnings #Call #Transcript